IBSSX Fees and Costs — Vy(r) Baron Growth Portfolio, Class S
Data updated: 2026-08-24
The net expense ratio is 1.25%: a 0.95% management fee, a 0.25% 12b-1 fee plus 0.29% other expenses, less a 0.24% fee waiver. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $80K in broker commissions, 0.0217% of average net assets, and portfolio turnover was 13%.
IBSSX Fees and Expenses
Annual operating expenses and sales charges of IBSSX. Prospectus, as of December 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.95% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.29% |
| Gross expense ratio | 1.49% |
| Fee waiver | −0.24% |
| Net expense ratio | 1.25% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
IBSSX Costs Over Time
On $10,000 invested in IBSSX, assuming 5% a year before costs, total costs come to $791 over 5 years, cutting the return by 1.34% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 1.25%) | $131 | $408 | $706 |
| Trading costs (broker commissions) | $2 | $7 | $12 |
| Lost growth on money paid in costs | $0 | $21 | $73 |
| Total costs | $134 | $436 | $791 |
| Value after costs | $10,366 | $11,140 | $11,972 |
| Impact on return, per year | 1.34% | 1.34% | 1.34% |
IBSSX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0217%
- Total broker commissions: $80K
- Bought from dealers (principal trades, not a cost): $143.0M
- Portfolio turnover (prospectus): 13%
- Securities lending: none during the year
IBSSX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| JEFFERIES LLC | $10K | 20.30% |
| Raymond James & Associates, Inc. | $7K | 13.25% |
| BOFA SECURITIES, INC. | $5K | 9.25% |
| STATE STREET GLOBAL MARKETS, LLC | $5K | 9.09% |
| WILLIAM BLAIR | $5K | 9.00% |
| CITIGROUP GLOBAL MARKETS INC. | $4K | 8.38% |
| STIFEL FINANCIAL CORP. | $4K | 8.12% |
| JONESTRADING | $4K | 7.97% |
| BTIG, LLC | $4K | 7.37% |
| WELLS FARGO SECURITIES, LLC | $4K | 7.26% |
IBSSX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| THE BANK OF NEW YORK MELLON | $137.8M | 96.37% |
| JEFFERIES LLC | $1.9M | 1.33% |
| MORGAN STANLEY & CO. LLC | $1.3M | 0.94% |
| J.P. Morgan Securities LLC | $1.1M | 0.77% |
| CitiGroup Global Markets Inc. | $843K | 0.59% |
Vy(r) Baron Growth Portfolio Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| VYRBX | Class R6 | 0.99% | — |
| IBGIX | Class I | 1.00% | — |
| IBSSX | Class S | 1.25% | — |
| IBCGX | Class S2 | 1.40% | — |
| IBSAX | Class ADV | 1.50% | — |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.